Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

494 trials with published results (13%)

Research Maturity

1864 completed trials (50% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.3%

236 terminated out of 3761 trials

Success Rate

88.8%

+2.2% vs benchmark

Late-Stage Pipeline

12%

454 trials in Phase 3/4

Results Transparency

27%

494 of 1864 completed with results

Key Signals

494 with results89% success236 terminated

Data Visualizations

Phase Distribution

2,502Total
Not Applicable (1584)
Early P 1 (19)
P 1 (171)
P 2 (274)
P 3 (189)
P 4 (265)

Trial Status

Completed1,864
Unknown574
Recruiting547
Terminated236
Not Yet Recruiting187
Active Not Recruiting149

Trial Success Rate

88.8%

Benchmark: 86.5%

Based on 1864 completed trials

Clinical Trials (3761)

Showing 20 of 20 trials
NCT06702527Terminated

Optimizing Clinical Outcomes in Patients Undergoing Mitral Transcatheter Edge-to-edge Repair (M-TEER) for Severe Functional Mitral Regurgitation Towards Improved Guideline-directed Medical Therapy

NCT06280820Enrolling By InvitationPrimary

Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)

NCT07278583RecruitingPrimary

Evaluation of Heart Failure Telemonitoring Eligibility Criteria

NCT07737964Phase 3Not Yet RecruitingPrimary

ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.

NCT06122779Phase 2Active Not RecruitingPrimary

Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

NCT04502316TerminatedPrimary

Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)

NCT07581587Not ApplicableRecruitingPrimary

Investigation of the Effect of Inspiratory Muscle Training and Dual-Task Inspiratory Muscle Training on Cognitive Functions in Heart Failure

NCT05719714Phase 1Active Not Recruiting

Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease

NCT07232030Not ApplicableEnrolling By InvitationPrimary

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

NCT05816265Phase 4TerminatedPrimary

Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure

NCT02962661Phase 1Recruiting

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

NCT06736574Phase 3RecruitingPrimary

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

NCT07701369Not ApplicableRecruitingPrimary

Relevance of Artificial Intelligence-Assisted Echocardiography for Left Ventricular Ejection Fraction Assessment in Geriatric Patients

NCT06847438Not ApplicableCompletedPrimary

Tailored Electronic Intervention to Improve Therapy in a Diverse Cohort of Patients With Heart Failure

NCT07492498Not ApplicableRecruiting

Novel Model of Integrated Care of Older Patients With Atrial Fibrillation to Prevent Heart Failure in Rural China

NCT07730827Recruiting

Community-Informed Interventions for Equitable Congestive Heart Failure Management in Primary Care

NCT07730268Not ApplicableEnrolling By InvitationPrimary

Vivio At-Home Study

NCT07492524Not ApplicableRecruiting

Novel Model of Integrated Care of Older Patients With Atrial Fibrillation and Heart Failure in Rural China (MIRACLE-AFHF)

NCT07492979Not ApplicableRecruiting

Conduction System Pacing vs. Biventricular Pacing for Cardiac Resynchronization Therapy

NCT07067658Not ApplicableRecruitingPrimary

Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk

Scroll to load more

Research Network

Activity Timeline